Amgen (AMGN) Price Target Raised at Jefferies Following Cardiologists Survey
Tweet Send to a Friend
Jefferies analyst Eun K. Yang, Ph.D. reiterated a Buy rating on Amgen (NASDAQ: AMGN) and boosted his price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
